Kalvista Pharmaceuticals Inc (KALV) support and resistance · rev $13.7M
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
This page maps Kalvista Pharmaceuticals Inc (KALV) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported KALV revenue for 2025-09-30 was $13.7M. Net income was -$158.9M. KALV currently screens at market cap $1.44B.
KALV currently screens at market cap $1.44B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new KALV 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the KALV quote page for the session range and the stock page for the full model.
Not investment advice.